US Bancorp’s Invesco Pharmaceuticals ETF PJP Stock Holding History

US Bancorp’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-165	Closed	-$13.6K	–	4325
2024 Q4	$13.6K	Buy	+165	New	+$14.2K	﹤0.01%	3299
2024 Q3	–	Sell	-100	Closed	-$8.22K	–	4159
2024 Q2	$8.22K	Hold	100	–	–	﹤0.01%	3378
2024 Q1	$8.02K	Buy	+100	New	+$7.75K	﹤0.01%	3404
2021 Q4	–	Sell	-1,650	Closed	-$128K	–	4199
2021 Q3	$128K	Hold	1,650	–	–	﹤0.01%	2171
2021 Q2	$133K	Hold	1,650	–	–	﹤0.01%	2156
2021 Q1	$130K	Hold	1,650	–	–	﹤0.01%	2130
2020 Q4	$118K	Buy	+1,650	New	+$110K	﹤0.01%	2135
2018 Q2	–	Sell	-87	Closed	-$5K	–	3669
2018 Q1	$5K	Hold	87	–	–	﹤0.01%	3326
2017 Q4	$6K	Sell	87 -602	-87%	-$38.6K	﹤0.01%	3290
2017 Q3	$45K	Buy	689 +602	+692%	+$38K	﹤0.01%	2617
2017 Q2	$5K	Hold	87	–	–	﹤0.01%	3229
2017 Q1	$5K	Sell	87 -896	-91%	-$52.4K	﹤0.01%	3210
2016 Q4	$55K	Hold	983	–	–	﹤0.01%	2388
2016 Q3	$60K	Hold	983	–	–	﹤0.01%	2349
2016 Q2	$63K	Buy	983 +896	+1,030%	+$56.4K	﹤0.01%	2283
2016 Q1	$5K	Buy	87 +4	+5%	+$245	﹤0.01%	3172
2015 Q4	$6K	Buy	+83	New	+$5.88K	﹤0.01%	3185

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

US Bancorp's PJP Position: Q1 2025 in Review

US Bancorp sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2025, closing a stake of 165 shares — an estimated $13.6K sold.

US Bancorp first reported a position in PJP in Q4 2015 and held it in 17 quarters. The position peaked at $133K in Q2 2021. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2025.

US Bancorp reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
US Bancorp sold 165 Invesco Pharmaceuticals ETF shares in Q1 2025, an estimated $13.6K.
US Bancorp first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 17 quarters.
US Bancorp's Invesco Pharmaceuticals ETF position peaked at $133K in Q2 2021.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.